CI.N Overview

The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.

Wall Street analysts forecast CI.N stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CI.N is335.63 USD with a low forecast of 300.00 USD and a high forecast of 378.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Cigna Group revenue for the last quarter amounts to 72.47B USD, increased 10.39

Cigna Group. EPS for the last quarter amounts to 4.55 USD, decreased -11.31

Cigna Group (CI.N) has 67700 emplpoyees as of March 10 2026.

Today CI.N has the market capitalization of 71.06B USD.